
Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. (GLSI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
glsi · stock forecast · 2 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$50.00
Consensus
$50.00
+130.9% upside
Low
$50.00
Median: $50 · Last Close: $21.65
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $20.57 | ↓ 5.00% |
1-day model range: $20.37–$20.77. Peak: $20.77 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $19 | -10.6% |
| 2028 | $18 | -15.8% |
| 2029 | $18 | -18.5% |
| 2030 | $17 | -20.0% |
| 2031 | — | -20.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GLSI · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-12-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-02-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-02-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-04-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-09-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-01-27 | Aegis Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Greenwich LifeSciences, Inc. (GLSI) stock. Of the recent 11 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover GLSI.
Analyst Recommendation Trends
GLSI analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-1.23
EPS Next Year
$-1.35
↑ 10.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast GLSI EPS of $-1.23 for the current fiscal year, based on estimates from 2 analysts. The GLSI revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The GLSI stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GLSI price target is $50.00 (+130.9% upside), with an analyst consensus of Buy.
The GLSI short-term stock prediction for tomorrow is $20.57 (-5.00%). The GLSI stock price prediction for 2027 estimates an average of $19. The GLSI stock prediction for 2030 projects a range of $16–$19.
Greenwich LifeSciences, Inc. trades on NASDAQ under the ticker GLSI. The GLSI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
GLSI forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month GLSI price target is $50.00, with a high forecast of $50.00 and a low of $50.00. The median price target is shown in the chart above when available. This implies +130.9% potential upside from the current price of $21.65.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.